SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Gabriela Godaly (tf)

Chairperson of the Board

  • Catharina Svanborg

Board

  • Carl-Johan Wachtmeister
  • Gabriela Godaly
  • Helena Lomberg

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 45,84 73,33 2023-06-28
Rolf Karlsson 6,42 3,16 2023-06-28
Avanza Pension 3,55 1,75 2023-06-28
Fredrik Herslow 3,47 1,71 2023-06-28
Jan Zetterberg 3,24 1,60 2023-06-28
Swedbank Försäkring 1,72 0,84 2023-06-28
Helena Lomberg 1,46 0,72 2023-06-28
Nordnet Pensionsförsäkring 1,42 0,70 2023-06-28
Monica Strömberg 1,11 0,55 2023-06-28
Peter Ryman 1,02 0,50 2023-06-28

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream